Case report
Open access
Sep 2026
Successful Conversion Surgery after S-1 plus oxaliplatin Plus Zolbetuximab for Initially Unresectable Gastric Cancer with Pancreatic Invasion: A Case Report
This case suggests that CLDN18.2-targeted therapy may facilitate curative resection in selected patients with initially unresectable gastric cancer.
Y. Fuse, H. Ono, Masanori Eguchi et al.
· Surgery Case Reports · 0 citations